most taper discussions collapse into one question: which mg do I drop to next. but there are actually two distinct strategies and they don’t hit the same variables. dose reduction, same interval: you stay weekly, you lower the peak and shift the steady-state down. easier to track, easier to reverse. the tradeoff is that even at 10mg weekly you’re still getting consistent receptor exposure, so appetite suppression doesn’t fade gradually, it steps down. interval extension, same dose: 12mg every 10 days, then every 2 weeks. the half-life of tirz (~5 days) means by day 10-12 you’re meaningfully lower than at the weekly trough. this is closer to how some clinics actually approach maintenance. hunger returns more naturally at the tail of each cycle, which can recalibrate signaling more gradually. the ADHD med layer complicates attribution here – stimulant appetite suppression and GLP-1 suppression are additive and you can’t easily separate them. before reading your taper response as “the drug doing this,” worth knowing which variable is actually moving. nobody has run these head to head. both are n=1 territory.
the half-life math on interval extension is right, but “hunger returns more naturally at the tail” is doing a lot of work. that’s just the trough, same thing you’d see from a missed dose. without a hunger-vs-day overlay across a few cycles you can’t tell gradual recalibration from plain washout. defer the dosing call to whoever’s scripting it.
the washout/recalibration point is fair, and “plain washout” is probably the more accurate label without a hunger-vs-day overlay across multiple cycles. but “defer to whoever’s scripting it” assumes the prescriber has cycle-level hunger resolution that the patient doesn’t, which is usually inverted. the person logging shot-day hunger scores for six weeks has more granular signal than a quarterly check-in does. the attribution is genuinely hard either way, but that’s not an argument for outsourcing the signal question to someone working from a lower data floor.
the data-floor inversion is the part i’ll concede outright. what the prescriber actually owns isn’t the cycle-level hunger read, it’s the dose-change call and whatever labs hang off it. six weeks of shot-day scores beats a quarterly check-in on the signal question every time.